Literature DB >> 2466324

Mitochondrial autoantigens in primary biliary cirrhosis. Association of disease-specific determinants with a subunit of complex I (NADH-ubiquinone reductase) of the inner mitochondrial membrane.

A Frostell1, I Mendel-Hartvig, B D Nelson, T H Tötterman, A Björkland, I C Ragan, M W Cleeter, S D Patel.   

Abstract

Anti-mitochondrial autoantibodies (AMA) from patients with primary biliary cirrhosis (PBC) were analysed for fine specificity by immunoblotting and enzyme-linked immunosorbent assay (ELISA). Inhibition ELISA showed that complex I (NADH-ubiquinone reductase) from beef heart mitochondria completely inhibited the binding of AMA to mitochondrial inner membranes (SMP), indicating that the major mitochondrial antigens are located in complex I. Immunoblot analysis of beef heart SMP, complex I and the iron sulphur (IP) subfraction of complex I revealed several antigens, one of which (75 kDa) reacted with all PBC sera but not with the additional autoimmune sera tested. Resolution of SMP or complex I by two-dimensional electrophoresis yielded in both preparations a polypeptide of 75 kDa with an isoelectric point of 6.4, which reacted with PBC serum and with rabbit antisera raised against the 75,000 subunit of complex I. In immunoblot experiments, the antigenicity of the 75,000 polypeptide in SMP, complex I, and the IP subfraction is increased by prior reduction of the sample with mercaptoethanol. This suggests a similarity to the PBC-specific 'M-2' antigen, which is also sensitive to sulphur reagents. The data indicate that the 75 kDa polypeptide of complex I is a major mitochondrial antigen binding AMA in PBC sera, and allows us to identify the location and probable function of the PBC antigen.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2466324     DOI: 10.1111/j.1365-3083.1988.tb01497.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  2 in total

1.  Anti-mitochondrial M2 Antibodies Enhance the Risk of Supraventricular Arrhythmias in Patients with Elevated Hepatobiliary Enzyme Levels.

Authors:  Hiroki Konishi; Koji Fukuzawa; Shumpei Mori; Seimi Satomi-Kobayashi; Kunihiko Kiuchi; Atsushi Suzuki; Yoshihiko Yano; Akihiro Yoshida; Ken-Ichi Hirata
Journal:  Intern Med       Date:  2017-07-15       Impact factor: 1.271

2.  Anti-mitochondrial Antibodies in Patients with Dilated Cardiomyopathy.

Authors:  Tetsuro Yokokawa; Akiomi Yoshihisa; Tomofumi Misaka; Takamasa Sato; Takashi Kaneshiro; Masayoshi Oikawa; Atsushi Kobayashi; Takayoshi Yamaki; Hiroyuki Kunii; Yasuchika Takeishi
Journal:  Intern Med       Date:  2021-01-15       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.